Bioxytran, Inc.
BIXT0.02389.17% ( +0.0020 )
Bioxytran, Inc. (BIXT)
Bioxytran, Inc., a clinical stage pharmaceutical company, focuses on the development, manufacture, and commercialization of therapeutic drugs to address viral i...
- Open
- 0.0234
- High
- 0.0254
- Low
- 0.0210
- Prev. Close
- 0.0218
- Volume
- 148.07K
- Turnover
- 3.55K
- Avg Price
- 0.0240
- Bid/Ask Ratio
- --
- Amplitude
- 20.18%
- 52wk High
- 0.0997
- Volume Ratio
- 4.07
- Turnover Ratio
- 0.13%
News
- Earnings Watch · May 15 at 12:37 PM
Bioxytran, Inc. | 10-Q: FY2026 Q1 Revenue: USD 0
- TradingView · May 15 at 12:31 PM
BIOXYTRAN, INC 1Q 2026: Net loss $(2.07M), EPS $(0.02) — 10-Q Summary
- TradingView · Apr 15 at 03:05 PM
Bioxytran 10-K: Net loss $2.12M, Loss per Share $(0.02)
- StockTitan · Apr 7 at 12:20 AM
NurExone Biologic’s U.S. Subsidiary Exo-Top and Florida-Based BioXtek Sign Strategic LOI for Exosome Manufacturing and Commercialization | NRXBF Stock News
- Tip Ranks · Apr 1 at 10:33 AM
Bioxytran Delays Annual 10-K Filing
- Tip Ranks · Mar 20 at 08:33 AM
Bioxytran Raises Capital to Advance Development and Commercialization
